F834-0620 Screening compound: N-[(furan-2-yl)methyl]-2-{5-methyl-4-oxo-6-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-3H,4H-thieno[2,3-d]pyrimidin-3-yl}acetamide

F834-0620 Screening compound: N-[(furan-2-yl)methyl]-2-{5-methyl-4-oxo-6-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-3H,4H-thieno[2,3-d]pyrimidin-3-yl}acetamide
F834-0620 Screening compound: N-[(furan-2-yl)methyl]-2-{5-methyl-4-oxo-6-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-3H,4H-thieno[2,3-d]pyrimidin-3-yl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F834-0620
N-[(furan-2-yl)methyl]-2-{5-methyl-4-oxo-6-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-3H,4H-thieno[2,3-d]pyrimidin-3-yl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F834-0620

Molecular Formula

C21H16N6O4S (C21 H16 N6 O4 S)

Compound Name

N-[(furan-2-yl)methyl]-2-{5-methyl-4-oxo-6-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-3H,4H-thieno[2,3-d]pyrimidin-3-yl}acetamide

IUPAC name

N-[(furan-2-yl)methyl]-2-{5-methyl-4-oxo-6-[3-(pyridin-4-yl)-124-oxadiazol-5-yl]-3H4H-thieno[23-d]pyrimidin-3-yl}acetamide

SMILES

Cc1c(-c2nc(-c3ccncc3)no2)sc(N=CN2CC(NCc3ccco3)=O)c1C2=O

InChI

InChI=1S/C21H16N6O4S/c1-12-16-20(32-17(12)19-25-18(26-31-19)13-4-6-22-7-5-13)24-11-27(21(16)29)10-15(28)23-9-14-3-2-8-30-14/h2-8,11H,9-10H2,1H3,(H,23,28)

InChI Key

BXSDJEWPDUNBLX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27197912

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

448.46

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.401

Distribution Coefficient, logD

2.401

Water Solubility, LogSw

-2.53

Polar Surface Area

99.295

Acid Dissociation Constant (pKa)

13.24

Base Dissociation Constant (pKb)

3.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

14.30

F834-0620 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F834-0620 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F834-0620?
Check Price and Availability of F834-0620, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F834-0620 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F834-0620
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F834-0620
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F834-0620 available by request